Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 12 August 2003
Vol. 2003, Issue 195, p. tw320
[DOI: 10.1126/stke.2003.195.tw320]

EDITORS' CHOICE

NEUROSCIENCE Retrograde Transport and ALS Therapy

Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by degeneration of the motor neurons for which there is no effective therapy. Kaspar et al. now show in a mouse model of ALS that injecting an adeno-associated viral vector carrying the neurotrophic factor, insulin growth factor 1 (IGF-1), into mouse limb muscles delays disease progression and prolongs survival of the animals. Travel of the viral vector by retrograde transport along the motor neurons that innervate the muscles delivered IGF-1 to the neuronal cell bodies.

B. K. Kaspar, J. Lladó, N. Sherkat, J. D. Rothstein, F. H. Gage, Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839-842 (2003). [Abstract] [Full Text]

Citation: Retrograde Transport and ALS Therapy. Sci. STKE 2003, tw320 (2003).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882